- Type
- 4
- Ref. number
- 568568-2024
- Estimated value
- 33,000,000 EUR
- CPV
- 73000000
The European Medicines Agency (EMA) has framework contracts in place with multiple contractors to perform quality, safety and efficacy studies to generate evidence to support regulatory decision-making for human and vete…
rinary medicines. As these framework contracts will expire in the last quarter of 2025, the Agency is preparing the launch of a new procurement procedure that will be open to economic operators established in the European Union (EU) and the European Economic Area (EEA), with the aim to sign the new
framework contracts in the last quarter of 2025. Given the different scientific areas in which EMA requires research, the new procurement procedure will be structured into different lots. While the exact information on the structure and sco